SCHEMBL9618002

SCHEMBL9618002

CCCCC/C=C\CCCCCCCOC=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.59
TRPV1 Q8NER1 2/20 0.59
LPAR3 Q9UBY5 3/20 0.50
LPAR1 Q92633 2/20 0.50
LPAR2 Q9HBW0 2/20 0.50
TSHR P16473 1/20 0.48
GMNN O75496 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
APEX1 P27695 1/20 0.47
CYP2C19 P33261 1/20 0.47
RECQL P46063 1/20 0.47
BLM P54132 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16351443 1.00 FAAH (0.59) FAAHTRPV1LPAR3LPAR1LPAR2
SCHEMBL21642616 1.00 FAAH (0.59) FAAHTRPV1LPAR3LPAR1LPAR2
SCHEMBL11093924 1.00 FAAH (0.59) FAAHTRPV1LPAR3LPAR1LPAR2
SCHEMBL6744603 1.00 FAAH (0.59) FAAHTRPV1LPAR3LPAR1LPAR2
SCHEMBL9618003 1.00 FAAH (0.59) FAAHTRPV1LPAR3LPAR1LPAR2
SCHEMBL611986 1.00 FAAH (0.59) FAAHTRPV1LPAR3LPAR1LPAR2
SCHEMBL13048889 1.00 FAAH (0.59) FAAHTRPV1LPAR3LPAR1LPAR2
SCHEMBL11072902 0.96 LPAR3 (0.55) FAAHTRPV1LPAR3LPAR1LPAR2
SCHEMBL727768 0.96 LPAR3 (0.55) FAAHTRPV1LPAR3LPAR1LPAR2
SCHEMBL10603998 0.96 LPAR3 (0.55) FAAHTRPV1LPAR3LPAR1LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4074154-A None JP disclosed
US-11155505-B2 Synthesis of pheromones and related materials via olefin metathesis PROVIVI, INC. (US) 2021-10-26 US disclosed
US-20200039900-A1 SYNTHESIS OF PHEROMONES AND RELATED MATERIALS VIA OLEFIN METATHESIS PROVIVI, INC. (US) 2020-02-06 US disclosed
WO-2018150379-A2 SYNTHESIS OF PHEROMONES AND RELATED MATERIALS VIA OLEFIN METATHESIS PROVIVI, INC. (US) 2018-08-23 WO disclosed
JP-H0474154-A NEW FORMIC ACID ESTER AND PRODUCTION THEREOF NITTO DENKO CORP 1992-03-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200039900-A1 SYNTHESIS OF PHEROMONES AND RELATED MATERIALS VIA OLEFIN METATHESIS OSBPL8, CYP51A1, ERG28 FAAH 1712/4885TRPV1 2335/4885LPAR3 3390/4885
US-11155505-B2 Synthesis of pheromones and related materials via olefin metathesis OSBPL8, CYP51A1, ERG28 FAAH 1712/4885TRPV1 2335/4885LPAR3 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.